Finance

Lists
531349:BOM
Panacea Biotec Ltd
₹359.70
+0.93%
(+3.30) 1D
Oct 16, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531349...
Open
₹354.35
High
₹363.70
Low
₹354.35
Mkt. cap
22.05B
Avg. vol.
4.95K
Volume
1.47K
52-wk high
₹647.50
52-wk low
₹293.10
EPS
-₹1.16
Shares outstanding
61.25M
No. of employees
2K
Open
₹354.35
High
₹363.70
Low
₹354.35
Mkt. cap
22.05B
Avg. vol.
4.95K
Volume
1.47K
52-wk high
₹647.50
52-wk low
₹293.10
EPS
-₹1.16
Shares outstanding
61.25M
No. of employees
2K
News stories
From web sources and news partners
Profile
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
About Panacea Biotec Ltd
CEO-
Employees2.1K
Founded1984
Headquarters-
SectorBiotechnology
Websitepanaceabiotec.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.41B
1.65B
1.67B
2.00B
Cost of goods sold
589.40M
679.30M
763.93M
1.02B
Cost of revenue
589.40M
679.30M
763.93M
1.02B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477.10M
405.30M
607.88M
441.60M
Operating expense
1.08B
939.70M
849.37M
1.00B
Total operating expenses
1.67B
1.62B
1.61B
2.02B
Operating income
-261.30M
32.90M
54.24M
-22.30M
Other non operating income
64.00M
22.80M
-149.85M
42.40M
EBT including unusual items
-191.70M
64.90M
-12.49M
35.70M
EBT excluding unusual items
-218.70M
37.20M
-47.72M
8.30M
Income tax expense
-51.60M
26.00M
-2.46M
13.70M
Effective tax rate
26.92%
40.06%
19.70%
38.38%
Other operating expenses
522.70M
449.90M
162.69M
480.30M
Net income
-139.20M
39.80M
5.13M
23.00M
Net profit margin
-9.86%
2.41%
0.31%
1.15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
41.64M
-
Interest expense
-21.40M
-18.50M
-5.60M
-11.80M
Net interest expenses
-21.40M
-18.50M
36.04M
-11.80M
Depreciation and amortization charges
83.40M
84.50M
78.80M
79.00M
EBITDA
-177.60M
113.44M
129.51M
60.35M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps